JP2022530615A5 - - Google Patents
Info
- Publication number
- JP2022530615A5 JP2022530615A5 JP2021562389A JP2021562389A JP2022530615A5 JP 2022530615 A5 JP2022530615 A5 JP 2022530615A5 JP 2021562389 A JP2021562389 A JP 2021562389A JP 2021562389 A JP2021562389 A JP 2021562389A JP 2022530615 A5 JP2022530615 A5 JP 2022530615A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic preparation
- patient
- preparation according
- fviii
- factor viii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962843221P | 2019-05-03 | 2019-05-03 | |
| US62/843,221 | 2019-05-03 | ||
| US201962845209P | 2019-05-08 | 2019-05-08 | |
| US62/845,209 | 2019-05-08 | ||
| PCT/US2020/031197 WO2020227162A1 (en) | 2019-05-03 | 2020-05-01 | Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530615A JP2022530615A (ja) | 2022-06-30 |
| JP2022530615A5 true JP2022530615A5 (https=) | 2023-05-08 |
| JP7692363B2 JP7692363B2 (ja) | 2025-06-13 |
Family
ID=73050863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562389A Active JP7692363B2 (ja) | 2019-05-03 | 2020-05-01 | 嚥下可能な薬物送達デバイスを使用する腸管の組織への送達のための凝固因子調製物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220118056A1 (https=) |
| EP (1) | EP3962516B1 (https=) |
| JP (1) | JP7692363B2 (https=) |
| KR (1) | KR20220004148A (https=) |
| CN (1) | CN114007638A (https=) |
| AU (1) | AU2020270420B2 (https=) |
| BR (1) | BR112021021904A2 (https=) |
| CA (1) | CA3137539A1 (https=) |
| MX (1) | MX2021013310A (https=) |
| WO (1) | WO2020227162A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8759284B2 (en) | 2009-12-24 | 2014-06-24 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US10689460B2 (en) | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| JP7370974B2 (ja) | 2017-11-07 | 2023-10-30 | ラニ セラピューティクス， エルエルシー | 嚥下可能薬物送達デバイスを使用する腸管組織への送達のための凝固因子調製物 |
| BR112021017993A2 (pt) * | 2019-03-13 | 2022-01-18 | Rani Therapeutics Llc | Preparações de agente terapêutico e métodos para liberação de fármacos em um lúmen do trato intestinal com o uso de um dispositivo ingerível de liberação de fármacos |
| KR20230154034A (ko) * | 2021-02-24 | 2023-11-07 | 라니 테라퓨틱스, 엘엘씨 | A형 혈우병의 치료 |
| WO2022218962A1 (en) * | 2021-04-13 | 2022-10-20 | Grifols Worldwide Operations Limited | Liquid composition comprising factor viii or factor viii/von willebrand factor complex |
| CN115300774B (zh) * | 2022-08-27 | 2024-01-30 | 深圳市资福医疗技术有限公司 | 一种药剂递送装置、释药方法及应用其的释药胶囊 |
| CN118221797B (zh) * | 2024-04-28 | 2025-02-18 | 内蒙古工业大学 | 一种具有脱敏效果的乳球蛋白肽及其应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR860984B (en) | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
| DE122007000007I2 (de) | 1986-04-09 | 2010-12-30 | Genzyme Corp | Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern |
| FR2619314B1 (fr) | 1987-08-11 | 1990-06-15 | Transgene Sa | Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant |
| AT405517B (de) | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-deletionsmutanten und analoge davon |
| EP3603624A1 (en) * | 2009-12-24 | 2020-02-05 | Rani Therapeutics, LLC | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8759284B2 (en) * | 2009-12-24 | 2014-06-24 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) * | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9629799B2 (en) * | 2010-12-23 | 2017-04-25 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9149617B2 (en) * | 2010-12-23 | 2015-10-06 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| PT3513804T (pt) * | 2011-07-08 | 2022-06-02 | Bioverativ Therapeutics Inc | Polipéptidos fator viii híbridos e quiméricos, e métodos de utilização dos mesmos |
| US20140019297A1 (en) * | 2012-07-10 | 2014-01-16 | Bootic, Inc. | Electronic Commerce System Incorporating Shopping Baskets |
| US11548940B2 (en) * | 2014-05-15 | 2023-01-10 | Rani Therapeutics, Llc | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) * | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| CN113546036A (zh) * | 2015-05-01 | 2021-10-26 | 拉尼医疗有限公司 | 药物组合物和用于制备包含多肽和/或蛋白质的固体块的方法 |
| DK3347050T3 (da) * | 2015-09-08 | 2025-04-14 | Rani Therapeutics Llc | PCSK9-antistofpræparater til afgivelse i et lumen i mave-tarmkanalen ved hjælp af en indtagelig enhed til afgivelse af lægemiddel |
| WO2017222337A1 (ko) * | 2016-06-24 | 2017-12-28 | 재단법인 목암생명과학연구소 | Fviii 및 vwf 인자를 포함하는 키메라 단백질 및 그 용도 |
| CN106279437B (zh) * | 2016-08-19 | 2017-10-31 | 安源医药科技（上海）有限公司 | 高糖基化人凝血因子viii融合蛋白及其制备方法与用途 |
| MX2019006444A (es) * | 2016-12-02 | 2019-10-30 | Bioverativ Therapeutics Inc | Métodos de tratamiento de artropatía hemofílica utilizando factores de coagulación quiméricos. |
| JP7370974B2 (ja) * | 2017-11-07 | 2023-10-30 | ラニ セラピューティクス， エルエルシー | 嚥下可能薬物送達デバイスを使用する腸管組織への送達のための凝固因子調製物 |
-
2020
- 2020-05-01 KR KR1020217038935A patent/KR20220004148A/ko active Pending
- 2020-05-01 CN CN202080047333.3A patent/CN114007638A/zh active Pending
- 2020-05-01 JP JP2021562389A patent/JP7692363B2/ja active Active
- 2020-05-01 WO PCT/US2020/031197 patent/WO2020227162A1/en not_active Ceased
- 2020-05-01 MX MX2021013310A patent/MX2021013310A/es unknown
- 2020-05-01 AU AU2020270420A patent/AU2020270420B2/en active Active
- 2020-05-01 EP EP20801591.7A patent/EP3962516B1/en active Active
- 2020-05-01 CA CA3137539A patent/CA3137539A1/en active Pending
- 2020-05-01 BR BR112021021904A patent/BR112021021904A2/pt unknown
-
2021
- 2021-10-29 US US17/515,284 patent/US20220118056A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022530615A5 (https=) | ||
| US6616914B2 (en) | Method for pulmonary and oral delivery of pharmaceuticals | |
| ES2260916T3 (es) | Preparacion en polvo para administracion a traves de la mucosa que contiene una medicina polimerica. | |
| JP2704019B2 (ja) | 薬剤含有マトリックス | |
| RU2002127804A (ru) | Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения | |
| CN101287457B (zh) | Treprostinil用于治疗神经性糖尿病的足部溃疡的用途 | |
| JP2022009125A5 (https=) | ||
| CA2066403A1 (en) | Transmucosal dosage form | |
| JP2003515533A5 (https=) | ||
| JP2005501110A5 (https=) | ||
| JP2022524446A5 (https=) | ||
| JP2005533021A5 (https=) | ||
| JP2002528502A5 (https=) | ||
| RU2002118115A (ru) | Препаративная форма стабильного водного раствора интерферона, способ ее приготовления и использования | |
| CN105380941A (zh) | 苯酞类化合物药物用途及其医药组合物 | |
| JP2007508284A5 (https=) | ||
| CN103977010B (zh) | 一种犬用复方赛拉嗪注射剂及其制备方法 | |
| JP2008266179A (ja) | 経肺用組成物 | |
| JP2012532852A (ja) | ２型糖尿病における食後高血糖の経頬粘膜治療の方法、および当該治療に用いられる医薬組成物 | |
| CN103664936A (zh) | 一类治疗创伤性脑损伤疾病的化合物及其用途 | |
| CN104758304B (zh) | 三七皂苷r1的医药用途 | |
| JP5435659B2 (ja) | トリプタンの経口腔粘膜投与用製剤形態 | |
| Ament et al. | Cardiac Arrest During Anesthesia: A Review of Cases | |
| Neustein et al. | Cardiovascular consequences of the concomitant administration of nifedipine and magnesium sulfate in pigs | |
| RU2681267C1 (ru) | Способ обезболивания при выполнении оперативного вмешательства по поводу удаления глаза |